Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Genetic Study Identifies 98% of Pancreatic Agenesis Causes
Tech & Innovation Genetic Study Identifies 98% of Pancreatic Agenesis Causes

The sudden medical realization that a newborn child lacks a vital internal organ often leaves medical teams and families in a desperate search for answers that historically remained out of reach for decades. Pancreatic agenesis represents one of the most severe manifestations of developmental

Can Hypoxia-Gated AAVs Revolutionize NSCLC Treatment?
Research & Development Can Hypoxia-Gated AAVs Revolutionize NSCLC Treatment?

The persistent challenge of treating non-small cell lung cancer lies not in the absence of potent therapeutic agents but in the inherent difficulty of delivering these treatments exclusively to malignant cells while preserving the integrity of surrounding healthy pulmonary tissue. Modern oncology

Can Outpatient Trials Expand Access to Cell Therapy?
Research & Development Can Outpatient Trials Expand Access to Cell Therapy?

The landscape of regenerative medicine has reached a critical juncture where the promise of engineered immune cells must finally overcome the logistical barriers of the ivory tower. For over a decade, chimeric antigen receptor T-cell therapies represented a double-edged sword: they offered

Do Jumping Genes Drive Brain Aging and Neurodegeneration?
Tech & Innovation Do Jumping Genes Drive Brain Aging and Neurodegeneration?

Hidden deep within the three billion letters of the human genome exists a restless population of genetic sequences that refuse to stay in one place for long. These are not the well-behaved protein-coding genes that dictate basic physiological traits like eye color or height; rather, they are the

Imaging Pioneer Simon Cherry Elected to the Royal Society
Tech & Innovation Imaging Pioneer Simon Cherry Elected to the Royal Society

The election of Simon R. Cherry to the Royal Society marks a monumental milestone in the field of medical physics, distinguishing him as one of the few global leaders whose contributions have fundamentally altered the landscape of diagnostic imaging and clinical research. As a Distinguished

Can DNA Immunotherapy Revolutionize Ovarian Cancer Care?
Research & Development Can DNA Immunotherapy Revolutionize Ovarian Cancer Care?

The diagnostic landscape for ovarian cancer remains notoriously difficult because symptoms are often subtle enough to be ignored until the malignancy has progressed to an advanced and life-threatening stage. For decades, the medical community relied on a standardized combination of aggressive

AI and Global Capital Reshape Healthtech and Life Sciences
Tech & Innovation AI and Global Capital Reshape Healthtech and Life Sciences

The convergence of generative artificial intelligence and a massive wave of global investment capital is currently rewriting the operational DNA of the life sciences and healthcare sectors with unprecedented speed. This transition is not merely about incremental software updates or faster computer

Northwestern’s Center for Synthetic Biology Marks Ten Years
Management & Regulatory Northwestern’s Center for Synthetic Biology Marks Ten Years

For the past ten years, the Northwestern University Center for Synthetic Biology has fundamentally altered how researchers perceive the inherent capabilities of living systems by treating genetic code as a programmable substrate for engineering solutions. Since its establishment, the center has

How Can CRISPRi Help Us Fight Drug-Resistant Fungi?
Tech & Innovation How Can CRISPRi Help Us Fight Drug-Resistant Fungi?

The global medical landscape currently faces an unprecedented surge in drug-resistant infections, with the fungal pathogen Candida albicans emerging as a particularly formidable adversary in healthcare settings. At the University of Guelph, a research team led by Dr. Rebecca Shapiro has developed a

Romania Sequences DNA of Native Tomatoes for the First Time
Management & Regulatory Romania Sequences DNA of Native Tomatoes for the First Time

The realization of a sophisticated genetic blueprint for Romania’s most cherished horticultural assets has fundamentally altered the landscape of agricultural science within the region. Researchers at the Plant Genetic Resources Bank (BRGV) in Buzau have successfully completed the first

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later